Hudson Bay Capital Management’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Hudson Bay Capital Management’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-45,131	Closed	-$6.33K	–	1036
2023 Q1	$6.33K	Sell	45,131 -245,300	-84%	-$24.8K	﹤0.01%	804
2022 Q4	$14.5K	Sell	290,431 -125,000	-30%	-$7.15K	﹤0.01%	850
2022 Q3	$16K	Sell	415,431 -184,569	-31%	-$20.4K	﹤0.01%	1073
2022 Q2	$66K	Hold	600,000	–	–	﹤0.01%	1060
2022 Q1	$108K	Sell	600,000 -50,000	-8%	-$12.6K	﹤0.01%	944
2021 Q4	$208K	Buy	+650,000	New	+$206K	﹤0.01%	903

Other funds holding DMAQR

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return

Hudson Bay Capital Management's DMAQR Position: Q2 2023 in Review

Hudson Bay Capital Management sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q2 2023, closing a stake of 45,131 shares — an estimated $6.33K sold.

Hudson Bay Capital Management first reported a position in DMAQR in Q4 2021 and held it in 6 quarters. The position peaked at $208K in Q4 2021. 29 funds tracked by Wall St. Rank hold DMAQR as of Q2 2023.

Hudson Bay Capital Management reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q2 2023 after selling out during the quarter.
Hudson Bay Capital Management sold 45,131 Deep Medicine Acquisition Corp. Rights shares in Q2 2023, an estimated $6.33K.
Hudson Bay Capital Management first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 6 quarters.
Hudson Bay Capital Management's Deep Medicine Acquisition Corp. Rights position peaked at $208K in Q4 2021.
29 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q2 2023.

Based on Hudson Bay Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.